SGHT
Sight Sciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
Ample Liquidity
High Gross Profit Margin
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SGHT
Sight Sciences, Inc.
An eyecare technology company focused on creating innovative solutions
Healthcare Equipment and Supplies
--
07/15/2021
NASDAQ Stock Exchange
216
12-31
Common stock
4040 Campbell Ave, Suite 100, Menlo Park CA 94025
--
Sight Sciences, Inc., was incorporated in Delaware in February 2010. The Company is an ophthalmic medical device company focused on the development and commercialization of surgical and non-surgical technologies for the treatment of common eye diseases. The company's business philosophy is based on the following principles: a comprehensive understanding of disease physiology; the development of transformative technologies designed to protect, protect and restore the natural physiological functions of diseased eyes; the development and marketing of products with proven clinical evidence, These products achieve effectiveness over current treatment models while minimizing complications or side effects; provide intuitive, patient-friendly intervention solutions for ophthalmologists and optometrists; and provide compelling economic value to all stakeholders, including patients, providers and third-party payers such as health insurance companies and commercial insurance companies.
Earnings Call
Q1/2025
Estimate EPS-0.23
Actual EPS-0.28
Estimate Revenue16.51M
Actual Revenue17
Sight Sciences' Q1 2025: Unpacking Contradictions in TearCare, OMNI Dynamics, and Tariff Strategies
May 19,2025 12:42
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.27
Actual EPS-0.23
Estimate Revenue18.18M
Actual Revenue19.60M
Sight Sciences' Q2 2025: Navigating Contradictions in TearCare Reimbursement and Market Dynamics
Aug 08,2025 06:59
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
SGHT has released its 2025 Q3 earnings. EPS was reported at -0.16, versus the expected -0.26, beating expectations. The chart below visualizes how SGHT has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SGHT has released its 2025 Q3 earnings report, with revenue of 19.91M, reflecting a YoY change of -1.25%, and net profit of -8.17M, showing a YoY change of 26.18%. The Sankey diagram below clearly presents SGHT's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
